BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 16999637)

  • 1. Uterine fibroids: a review of health-related quality of life assessment.
    Williams VS; Jones G; Mauskopf J; Spalding J; DuChane J
    J Womens Health (Larchmt); 2006 Sep; 15(7):818-29. PubMed ID: 16999637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic impact of uterine fibroids in the United States: a summary of published estimates.
    Mauskopf J; Flynn M; Thieda P; Spalding J; Duchane J
    J Womens Health (Larchmt); 2005 Oct; 14(8):692-703. PubMed ID: 16232101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroid volume, location and symptoms in women undergoing uterine artery embolization: does size or position matter?
    Arleo EK; Masheb RM; Pollak J; McCarthy S; Tal MG
    Int J Fertil Womens Med; 2007; 52(2-3):111-20. PubMed ID: 18320870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexual functioning and psychological well-being after uterine artery embolization in women with symptomatic uterine fibroids.
    Voogt MJ; De Vries J; Fonteijn W; Lohle PN; Boekkooi PF
    Fertil Steril; 2009 Aug; 92(2):756-61. PubMed ID: 18692808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine artery embolization for symptomatic fibroids: short-term versus mid-term changes in disease-specific symptoms, quality of life and magnetic resonance imaging results.
    Scheurig C; Gauruder-Burmester A; Kluner C; Kurzeja R; Lembcke A; Zimmermann E; Hamm B; Kroencke T
    Hum Reprod; 2006 Dec; 21(12):3270-7. PubMed ID: 16877371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids.
    Wallace K; Zhang S; Thomas L; Stewart EA; Nicholson WK; Wegienka GR; Wise LA; Laughlin-Tommaso SK; Diamond MP; Marsh EE; Jacoby VL; Anchan RM; Venable S; Larry GM; Lytle B; Wang T; Myers ER
    Fertil Steril; 2020 Mar; 113(3):618-626. PubMed ID: 32192594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of uterine fibroids in five European countries.
    Downes E; Sikirica V; Gilabert-Estelles J; Bolge SC; Dodd SL; Maroulis C; Subramanian D
    Eur J Obstet Gynecol Reprod Biol; 2010 Sep; 152(1):96-102. PubMed ID: 20598796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further validation of the uterine fibroid symptom and quality-of-life questionnaire.
    Coyne KS; Margolis MK; Bradley LD; Guido R; Maxwell GL; Spies JB
    Value Health; 2012 Jan; 15(1):135-42. PubMed ID: 22264981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study.
    Salaffi F; Cimmino MA; Malavolta N; Carotti M; Di Matteo L; Scendoni P; Grassi W;
    J Rheumatol; 2007 Jul; 34(7):1551-60. PubMed ID: 17516618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound-guided radiofrequency ablation of symptomatic uterine fibroids: short-term evaluation of effect of treatment on quality of life and symptom severity.
    Iversen H; Lenz S; Dueholm M
    Ultrasound Obstet Gynecol; 2012 Oct; 40(4):445-51. PubMed ID: 22378629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of uterine fibromyoma with bilateral uterine artery embolization: state of the art].
    Lupattelli T; Clerissi J; Basile A; Minnella DP; Donati Sarti R; Gerli S; Di Renzo G
    Minerva Ginecol; 2007 Aug; 59(4):427-39. PubMed ID: 17923833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of uterine fibroids on quality of life: a national cross-sectional survey.
    Hervé F; Katty A; Isabelle Q; Céline S
    Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():32-37. PubMed ID: 30099225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine fibroid embolization.
    White AM; Spies JB
    Tech Vasc Interv Radiol; 2006 Mar; 9(1):2-6. PubMed ID: 17145478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of the psychosocial impact of fibroids before and after treatment.
    Go VAA; Thomas MC; Singh B; Prenatt S; Sims H; Blanck JF; Segars JH
    Am J Obstet Gynecol; 2020 Nov; 223(5):674-708.e8. PubMed ID: 32474012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of symptomatic fibroids: conservative surgical treatment modalities other than abdominal or laparoscopic myomectomy.
    Istre O
    Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):735-47. PubMed ID: 18328788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women.
    Marsh EE; Al-Hendy A; Kappus D; Galitsky A; Stewart EA; Kerolous M
    J Womens Health (Larchmt); 2018 Nov; 27(11):1359-1367. PubMed ID: 30230950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in the treatment of angina.
    Akhras KS; Burch SP; Dedhiya SD; Sood VC
    Heart Dis; 2000; 2(3):201-16. PubMed ID: 11728262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymptomatic uterine fibroids.
    Divakar H
    Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):643-54. PubMed ID: 18375184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial.
    Volkers NA; Hehenkamp WJ; Smit P; Ankum WM; Reekers JA; Birnie E
    J Vasc Interv Radiol; 2008 Jul; 19(7):1007-16; quiz 1017. PubMed ID: 18589314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-cultural comparisons of health-related quality of life in Australian and Japanese midlife women: the Australian and Japanese Midlife Women's Health Study.
    Anderson DJ; Yoshizawa T
    Menopause; 2007; 14(4):697-707. PubMed ID: 17438514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.